Hudbay Minerals Inc. (HBM)vsVertex Pharmaceuticals Inc (VRTX)
HBM
Hudbay Minerals Inc.
$20.02
+5.65%
BASIC MATERIALS · Cap: $7.95B
VRTX
Vertex Pharmaceuticals Inc
$454.97
-0.27%
HEALTHCARE · Cap: $113.95B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 443% more annual revenue ($12.00B vs $2.21B). VRTX leads profitability with a 32.9% profit margin vs 25.7%. HBM appears more attractively valued with a PEG of 2.09. HBM earns a higher WallStSmart Score of 75/100 (B).
HBM
Strong Buy75
out of 100
Grade: B
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+60.8%
Fair Value
$67.39
Current Price
$20.02
$47.37 discount
Margin of Safety
+36.5%
Fair Value
$716.04
Current Price
$454.97
$261.07 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 26 of every $100 in revenue as profit
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 29.8%
Revenue surging 25.3% year-over-year
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 23 in profit
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Distress zone — elevated risk
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : HBM
The strongest argument for HBM centers on Profit Margin, P/E Ratio, Price/Book. Profitability is solid with margins at 25.7% and operating margin at 29.8%. Revenue growth of 25.3% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.
Bear Case : HBM
The primary concerns for HBM are PEG Ratio, Piotroski F-Score, Altman Z-Score.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
HBM profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.
HBM carries more volatility with a beta of 2.03 — expect wider price swings.
HBM is growing revenue faster at 25.3% — sustainability is the question.
VRTX generates stronger free cash flow (349M), providing more financial flexibility.
Bottom Line
HBM scores higher overall (75/100 vs 66/100), backed by strong 25.7% margins and 25.3% revenue growth. VRTX offers better value entry with a 36.5% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hudbay Minerals Inc.
BASIC MATERIALS · COPPER · USA
Hudbay Minerals Inc., a diversified mining company, focuses on the discovery, production and marketing of base and precious metals in North and South America. The company is headquartered in Toronto, Canada.
Visit Website →Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?